FORUM DE LA RECHERCHE EN CANCROLOGIE

AUVERGNE-RHNE-ALPES 2018

BOOK DES COMMUNICATIONS

ORALES ET POSTERS

Table des matires Bioinformatics, Modeling ............................................................................................. 7

A Meta-Analysis of Breast Cancer Cell Lines Transcriptomic Profiles: Finding the Right Cell Line

Model ................................................................................................................. 8

Detection of Genetically Altered Proteins in Cancer by Proteogenomics ................................ 9

Interaction des radiations ionisantes avec les systmes biologiques : modlisation multi-chelle

pour comprendre et optimiser les radiothrapies innovantes ............................................ 10

Circadian Clock and Cancer: A Network Biology Perspective Sheds Light on Adhesion Signaling .. 11

Personalized Oncology with Artificial Intelligence: The Case of Temozolomide ...................... 12

NanOx, a New Multiscale Model to Predict Ion RBE in Hadrontherapy .................................. 13

Modlisation physique, chimique et biologique pour la radiothrapie amliore par les

nanoparticules fort-Z : vers une meilleure comprhension de leffet radiosensibilisant ......... 14

DNA Methylation-Wide Deregulation by Estrogen Hormones in Breast Cancer ........................ 15

Mise en place dun pipeline danalyse de puce Affymetrix Cytoscan dans le cadre du projet IMODI

....................................................................................................................... 16

NGS et France Gnomique 2025 - quels challenges en pratique ? ....................................... 17

Clinical Research ..................................................................................................... 18

Intrt dune rflexion anticipe du la limitation des soins dans un service doncologie

thoracique : une tude prospective ........................................................................... 19

Mtastase cutane ombilicale (ou nodule de Sur Marie-Joseph) rvlant un carcinome

gastrique : propos dun cas ................................................................................... 20

Registre et profil des cancers en Rpublique Dmocratique du Congo : cas du centre

danatomopathologie LEBOMA ................................................................................. 21

Profil pidmiologique, clinique et volutif du Sarcome de Kaposi chez les personnes vivant avec

le VIH/SIDA de janvier 2000 janvier 2003 .................................................................. 22

Evaluation du polymorphisme gntique des rgions rgulatrices du gne EGFR dans les

carcinomes pulmonaires ......................................................................................... 23

Stratification of Head and Neck Cancers: DNA Repair Enzyme Signature to Identify Resistance and

Toxicity Biomarkers .............................................................................................. 24

La qualit des donnes du registre du cancer de Batna ? 2010 2014 .................................. 26

Tabac et cancers du larynx, tude cas-tmoins Batna,Algrie,2008-2011 ........................... 27

Nanomedicine, Health Technologies ............................................................................. 28

Targeting Cancer Cells by Membrane Physicochemical Properties: An Alternative Way to Improve

Drug Delivery ...................................................................................................... 29

Nanoscintillators-Induced Deep-Tissue Photodynamic Therapy Upon X-Rays Irradiation ............ 30

Nanotechological Strategies for Pentamidine Delivery in Cancer Treatment .......................... 31

New siRNA-Based Nanotherapy for Inflammatory Bowel Diseases, Targeting Janus Kinase 1/3 .... 32

Developement of a Beam Tagging Diamond Hodoscope for Online Ion Range Verification in

Hadrontherapy .................................................................................................... 33

Anti-Tumor Efficacy of Hyaluronan-Based Nanoparticles for the Co-Delivery of Drugs in Lung

Cancer .............................................................................................................. 34

Preclinical Evaluation of an Innovative Drug Delivery System Based on Immunostimulant

Nanoparticles against Chronic HBV Infections ............................................................... 35

Photoactivation of Iron Nanoparticles for the Improvement of Glioma Treatment .................. 37

Calcitriol-Loaded Nanoparticle Development for Cancer Therapy Applications ....................... 38

Development of New RF sensor for Early Diagnosis of Breast Cancer ................................... 39

Pretargeted Imaging of Peritoneal Carcinomatosis Using Bioorthogonal Chemistry .................. 40

Mapping Drug Mechano-Sensitivity in Tumour Spheroids with Brillouin Light Scattering ............ 41

Multi-Scale Mechanical Characterization of Prostate Cancer Cell Lines: Relevant Biological Markers

to Evaluate the Cell Metastatic Potential .................................................................... 42

Infiltrative Glioma Detected by Fast Field Cycling NMR: A Nuclear Magnetic Resonance Technology

of Low and Variable Magnetic Fields .......................................................................... 43

In Vivo and Ex Vivo Multimodal Imaging Tracking of Gold Quantum Clusters for Cancer

Applications ........................................................................................................ 44

Evaluation of the Efficacy of 5FU-Loaded Lipid Nanoparticles Using 2D and 3D In Vitro Models ... 45

Evaluation of Self-Assembled Nanogels Containing Boron for Tumor Imaging and Therapy ......... 46

Development of FACS-Based High Throughput RNAi Screening to Identify New Therapeutic Targets

in Cancer ........................................................................................................... 47

Use of LC-MS Multiplex mAbs Analysis in Drug Development ............................................. 48

Environment, Nutrition and Epidemiology ...................................................................... 49

Prise en charge en activit physique adapte pendant et aprs un cancer du sein par lapport des

objets connects et de lducation thrapeutique : tude DISCO ....................................... 50

Les cancers digestifs dans la wilaya dAnnaba - Donnes du registre du cancer 2014-2015 ........ 51

Survival of Childhood Cancer in a Paediatric Ward ......................................................... 52

Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk in a Prospective Cohort Study . 53

Development and Performance Evaluation of a GIS-Based Metric to Assess Exposure to Airborne

Pollutant Emissions from Industrial Sources ................................................................. 54

Anthropometry and Risk of Breast Cancer Among Premenopausal Women in Latin America: Results

from the PRECAMA Study ........................................................................................ 55

Evaluate the Link Between Biomarker of Endogenous Lipogenesis, DNA Methylation Patterns and

Breast Cancer in EPIC ............................................................................................ 56

Association Between Serum Phospholipid Fatty Acid Levels and Adiposity in Lebanon .............. 57

A GIS-Based Method to Define Geographical Determinants of Environmental Exposure to

Agricultural Pesticides in France ............................................................................... 58

Development of a Software Based on Automatic Multi-Temporal Aerial Images Classification to

Assess Retrospective Environmental Exposures to Pesticides in Epidemiological Studies ........... 59

Development of a Sensitive Analytical Method for the Measurement of Sex Steroids in

Plasma/Serum Samples from Large-Scale Epidemiological Studies ...................................... 60

Prolymphome: A Multicenter Study to Assess the Feasibility of a Systematic Screening for

Occupational Exposures in Hematologic Malignancies ..................................................... 61

Predicting Clinical Benefits of Combined Bevacizumab and Paclitaxel Therapy for HER-2 Negative

Metastatic Breast Cancer: A Serum NMR Metabolomics Investigation ................................... 63

Mammary Myoepithelial Cells: Key Actors in Breast Cancer Associated with Obesity? ............... 64

Use of Dietary Supplements in Soy Isoflavones and Risk of Breast Cancer Among Women Aged Over

50 Years: Results From The E3N Prospective Cohort ....................................................... 65

Seasonal Variations of Exposure to Agricultural Pesticides in Residents Proximate to Vineyards:

SIGEXPOSOME Study .............................................................................................. 66

Progression and Tumor Resistance, Innovative Therapies .................................................... 67

Nucleotide Metabolism and Cancer Cell Aggressiveness ................................................... 68

Paired Cell for Deciphering Lung Tumorigenesis and Preclinical Drugs Evaluation ................... 69

Epithelial Cells in Hypoxic Environnement: The Race to Oxygen! Is